Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter June 2020

News: Preclinical Study of SLS-004, Potential Parkinson’s Gene Therapy, Starting
Seelos Therapeutics announced it is beginning, earlier than expected, a preclinical study into its investigational gene therapy candidate for Parkinson’s disease called SLS-004. Nerve cell damage in Parkinson’s is caused by the buildup of toxic forms of the alpha-synuclein protein, and resulting clumps of misfolded proteins known as Lewy bodies. These toxic aggregates damage and eventually kill nerve cells — called dopaminergic neurons — in a region of the brain that regulates muscle movement and coordination.

Conference: Gene and Cell Therapy: Regulatory CMC, Quality Development and Manufacturing
Hosted by the leading experts, Gene and Cell Therapy LIVE Webinar, 23 June 2020, will provide an opportunity to participate in the interactive discussion on the recent strategies, perspectives and expectations in the field. Learn more about successful process development, manufacturing, quality, CMC technical and regulatory requirements for ATMPs (advanced therapy medicinal products), featuring gene and cell therapy.
Register now...

Conference: Gene Therapy for Neurological Disorders Europe
Gene Therapy for Neurological Disorders Europe, 15 July 2020, is dedicated to solving the translational drug development challenges encountered in the development of gene therapies for neurological disorders. Industry pioneers from the leading pharma and biotech companies including Avexis, uniQure, and Biogen will share how to improve the translatability of small and large animal models, develop innovative delivery approaches to guarantee delivery of vector and understand the realities of immunogenicity challenges in the CNS. Join this definitive, niche digital conference to accelerate the development of your gene therapy pipeline and address the significant unmet need in neurological indications.
Register now...

Conference: Innate Killer Summit 2020
Improving Patient Care by Advancing Innate Understanding & Enhancing Innate Cell Therapies. Over 200 experts will be taking part from 24-25 August 2020 to hear the latest developments in innate cell therapy development. Become part of the Innate Killer Summit to discover how to target solid tumor indications with off-the-shelf innate cell therapies! Advance your understanding of the fundamental biology of NK cells through discovering mechanisms of cytotoxicity and cell education in order to you design better NK cell therapies.
Register now...

Conference: Gene Therapy Analytical Development Europe
With hotly anticipated gene therapy clinical progress in Europe, Gene Therapy Analytical Development Europe, 1-3 September 2020, will be the industry‘s definitive conference, designed to unite the analytical experts of gene therapy pharma and biotech to navigate the challenging regulatory landscape and develop robust analytical tools. Our goal is to deliver an industry-focused event tailored specifically to the analytical challenges facing gene therapy developers, enabling ‘boots on the ground’ scientists to overcome their challenges to guarantee the consistency, quality and safety of gene therapy products.
Register now...

- 23 June 2020, Gene and Cell Therapy: Regulatory CMC, Quality Development and Manufacturing, Virtual event
- 8 - 9 July 2020, Formulation and Drug Delivery conference - Cell & Gene Therapy Biomanufacturing: Insights, Key Strategies & Novel Approaches, Virtual event
- 7 - 9 July 2020, Onco Cell Therapy Summit USA, Virtual event
- 15 July 2020, Gene Therapy for Neurological Disorders Europe, Online event
- 21 - 23 July 2020, Bioprocessing Summit Europe, Virtual event
- 22 July 2020, RNAi-Based Therapeutics Summit, Virtual event
- 4 - 6 August 2020, Gene Therapy Immunogenicity Summit, Boston, MA
- 4 - 6 August 2020, Gene Therapy for Ophthalmic Disorders, Boston, MA
- 5 - 7 August 2020, Neuroimmunology Drug Development Summit - Translating Neuroimmunological Mechanisms into Clinically Effective Neurodegenerative Targeting Therapeutics, Boston, MA
- 18 - 20 August 2020, 2nd Annual Cell Engager Summit, Boston, MA
- 24 - 26 August 2020, Innate Killer Summit 2020, San Diego, CA
- 24 - 26 August 2020, World Orphan Drug Congress USA, Gaylord, National Harbor, Maryland
- 24 - 28 August 2020, 12th annual Bioprocessing Summit, Boston, MA
- 31 August - 4 September 2020, PEGS: The Essential Protein Engineering and Cell Therapy Summit - Cell and Gene Therapies, Boston, MA
- 1 - 3 September 2020, Gene Therapy Analytical Development Europe, London, UK
- 7 - 9 September 2020, 15th Annual World Advanced Therapies Congress, London, UK
- 14 - 17 September 2020, CAR-TCR Summit USA, Boston, MA
- 15 - 17 September 2020, Bioanalytical strategies for Cell & Gene Therapies workshop, Málaga, Spain
- 16 - 17 September 2020, Oligonucleotide Therapeutics and Delivery conference, London, UK
- 21 - 22 September 2020, Bioproduction Summit on Advances in AAV for Gene Therapy & Protein Production, San Francisco, CA
- 22 - 24 September 2020, Advanced Therapies Manufacturing Strategy Summit, Virtual event
- 22 - 25 September 2020, Patient Centric Cell Therapy Supply Chain Summit, Philadelphia, PA
- 23 - 25 September 2020, American Society of Gene & Cell Therapy (ASGCT) Policy Summit 2020, Online event
- 1 – 3 October 2020, 2020 Cell Therapies and Immunotherapy Conference, Naples, Italy
- 6 – 7 October 2020, Cell Series UK 2020 - 6th Annual Cell & Gene Therapy Manufacturing Congress, London, UK
- 15 - 16 October 2020, Global Cell and Gene Therapy Innovation Leaders Shanghai Forum - Asia Pharma R&D Leaders Summit 2020, Shanghai, China
- 20 – 21 October 2020, Cell & Gene Therapy Research & Development Congress Asia 2020, Taipei, Taiwan
- 20 – 23 October 2020, XXVIII Congress of the European Society of Gene and Cell Therapy (ESGCT), Edinburgh UK
- 26 - 27 October 2020, 2nd Annual Gene and Cell Therapy: Quality Developments to Commercialization Summit, Munich, Germany
- 26 - 28 October 2020, Allogeneic Cell Therapies Summit 2020, Boston, MA
- 3 - 4 November 2020, 6th Annual Biopharma Development and Production (BDP) Week - 2nd Annual Cell and Gene Therapy Manufacturing, Shanghai Hongqiao, China


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net, Zika Virus Net and Corona Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?